Foley & Lardner LLP advised Bluestone Equity Partners on the deal. Bluestone Equity Partners (Bluestone), the global sports, media, and entertainment (SME) private equity firm, announced...
Bluestone Equity Partners’ Investment into PMY Group
Eyenuk’s $26 Million Series A Financing Round
Foley & Lardner LLP represented AXA IM Alts on the deal. AXA IM Alts, a global leader in alternative investments, acted as lead investor in the $26...
Material Newborn Health Innovations’ $26 Million Financing Round
Foley & Lardner LLP represented AXA IM Alts on the deal. AXA IM Alts, a global leader in alternative investments with over $190 billion of assets...
Flores’ Recapitalization
Foley & Lardner LLP advised Century Equity Partners on the deal. Century Equity Partners and its portfolio company Flores & Associates LLC (Flores), a leading provider...
CXL Ophthalmics’ $32 Million Series A Round of Fundraising
Mintz represented CXL Ophthalmics (CXLO) on the deal while Foley & Lardner LLP represented AXA IM Alts. CXL Ophthalmics (CXLO), a clinical-stage company developing a minimally-invasive...
FAT Brands’ Acquisition of Fazoli’s Restaurant Chain
Foley & Lardner LLP advised FAT Brands on the deal. FAT (Fresh. Authentic. Tasty.) Brands Inc. (“FAT Brands” or the “Company”) announced its acquisition of Fazoli’s for...
Aspirus’ Acquisition of Seven Hospitals, 21 Physician Clinics, and Air and Ground Medical Transport Services
Foley & Lardner advised Aspirus, Inc. on the deal. Aspirus, Inc., a non-profit, community-directed health system based in Wausau, Wisconsin, announced its assumption of ownership from Ascension...